[go: up one dir, main page]

NL7511089A - IMMUNOLOGICAL CONNECTIONS. - Google Patents

IMMUNOLOGICAL CONNECTIONS.

Info

Publication number
NL7511089A
NL7511089A NL7511089A NL7511089A NL7511089A NL 7511089 A NL7511089 A NL 7511089A NL 7511089 A NL7511089 A NL 7511089A NL 7511089 A NL7511089 A NL 7511089A NL 7511089 A NL7511089 A NL 7511089A
Authority
NL
Netherlands
Prior art keywords
immunological
connections
immunological connections
Prior art date
Application number
NL7511089A
Other languages
Dutch (nl)
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NL7511089A publication Critical patent/NL7511089A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Metal Rolling (AREA)
NL7511089A 1974-09-20 1975-09-19 IMMUNOLOGICAL CONNECTIONS. NL7511089A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB41037/74A GB1509707A (en) 1974-09-20 1974-09-20 Immunological compounds

Publications (1)

Publication Number Publication Date
NL7511089A true NL7511089A (en) 1976-03-23

Family

ID=10417824

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7511089A NL7511089A (en) 1974-09-20 1975-09-19 IMMUNOLOGICAL CONNECTIONS.

Country Status (7)

Country Link
JP (1) JPS5161640A (en)
DE (1) DE2541931A1 (en)
DK (1) DK141773B (en)
FR (1) FR2285145A1 (en)
GB (1) GB1509707A (en)
NL (1) NL7511089A (en)
SE (1) SE7510505L (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067971A (en) * 1976-05-13 1978-01-10 The Procter & Gamble Company Therapeutic composition
JPS54132503A (en) * 1978-04-07 1979-10-15 Kayaku Antibiotic Research Co Immune globulin combined neocarcinostatin
JPS5665829A (en) * 1979-11-02 1981-06-03 Kureha Chem Ind Co Ltd Antitumor agent
JPS5592325A (en) * 1978-12-29 1980-07-12 Kureha Chem Ind Co Ltd Antitumor agent and its preparation
US4315851A (en) 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
JPS5665828A (en) * 1979-11-02 1981-06-03 Kureha Chem Ind Co Ltd Antitumor agent
EP0037388B1 (en) * 1980-03-31 1984-12-12 Institut International De Pathologie Cellulaire Et Moleculaire Pharmaceutical forms, their preparation and compositions containing the same
JPS58118520A (en) * 1982-01-09 1983-07-14 Hidematsu Hirai Antitumor proteinic complex and preparation thereof
JPS59186924A (en) * 1983-04-08 1984-10-23 Kureha Chem Ind Co Ltd Antitumor agent bonded with human immunoglobulin
GB2148299B (en) * 1983-09-01 1988-01-06 Hybritech Inc Antibody compositions of therapeutic agents having an extended serum half-life
DE3513572A1 (en) * 1985-04-16 1986-10-16 Karl Prof. Dr.med. 7302 Ostfildern Theurer Preparation of products for specifically influencing the humoral and cellular immune response
JPS62228025A (en) * 1985-12-27 1987-10-06 Teijin Ltd Production of antibody complex
WO1988007553A1 (en) * 1987-03-26 1988-10-06 Teijin Limited Process for preparing antibody complex
US5773435A (en) * 1987-08-04 1998-06-30 Bristol-Myers Squibb Company Prodrugs for β-lactamase and uses thereof
AU649275B2 (en) * 1990-11-06 1994-05-19 Bristol-Myers Squibb Company Prodrugs for beta-lactamase and uses thereof
DE4122210C2 (en) * 1991-07-04 1999-04-01 Deutsches Krebsforsch Tumor-active compound-serum albumin conjugates, process for their preparation and their use

Also Published As

Publication number Publication date
DK141773B (en) 1980-06-16
SE7510505L (en) 1976-03-22
DE2541931A1 (en) 1976-04-01
FR2285145A1 (en) 1976-04-16
DK141773C (en) 1980-11-03
FR2285145B1 (en) 1980-05-30
JPS5161640A (en) 1976-05-28
GB1509707A (en) 1978-05-04
DK422475A (en) 1976-03-21

Similar Documents

Publication Publication Date Title
NL7510505A (en) TETRACYCLICAL CONNECTIONS.
SE7500929L (en) MOUTHPHEAD.
SE413001B (en) STRENGGJUTNINGSANLEGGNING.
NL7511089A (en) IMMUNOLOGICAL CONNECTIONS.
NO143759C (en) SJOEPLATTFORMANORDNING.
NL7504306A (en) SEMICONDUCTOR CONNECTION.
SE7503535L (en) STREPTOMYCETAL AMTIBIOTICS.
SE7508358L (en) GYMNASTIKAPARAT.
NO149010C (en) KOMPRESSOR.
DK135492B (en) Lastpalle.
SE7409757L (en) PRESSTATIV.
SE7508546L (en) RELIEFBOKSTEVER.
NO141322C (en) NoeD-DOERAAPNER.
NL7503268A (en) CYCLICAL CONNECTIONS.
NO138352C (en) YSTETANK.
SE7507132L (en) HOGTALARGALLER.
NL7505400A (en) BICYCLICAL CONNECTIONS.
DK137669B (en) Piberiver.
BE809593A (en) ENGINE-SELF-PROPELLER.
NL7500945A (en) MOLLFALL.
NL7416085A (en) HEIBLOK.
BE814204A (en) WORKCLOTHES.
NL7503137A (en) TRICYCLICAL CONNECTIONS.
SE7503576L (en) METALHALID COMPLEX.
NO139660C (en) SEILING AID.

Legal Events

Date Code Title Description
BV The patent application has lapsed